semaglutide patent canada Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Canada approves first generic version

[81] Society and culture [edit] Legal status [edit] In December 2016, a new drug application was filed with the US Food and Drug Administration (FDA), and in October 2017, an FDA advisory committee approved it unanimously

Cruz-Jentoft AJ, Sayer AA

One group continued with Wegovy, while the other switched to a placebo, stopping the medication abruptly without a taper (a gradual reduction of the dose over many months before coming off)

While most people tolerate semaglutide well, some do experience side effects, including skin reactions

Frequently asked questions What happens if the doctor decides I'm not a candidate for Ozempic